UNIFORM CONTROLLED DANGEROUS SUBSTANCES ACT
- Section 2-801 - Definitions
- Section 2-802 - Clinical trials using cannabidiol - Principal investigators
- Section 2-803 - Approved cannabidiol for use in clinical trials
- Section 2-804 - Immunity
- Section 2-805 - Approval - Termination date - Reporting - Rules
- Section 2-901 - Drug Possession Diversion Program - District attorney discretion to refer
- Section 2-902 - Deferred prosecution - Fees - Drug Possession Diversion Program Fund
- Section 2-903 - Duties of district attorney staff members
- Section 2-904 - Drug Possession Diversion Program - Annual report
- Section 2-1001 - Opioid Overdose Fatality Review Board - Powers and duties
- Section 2-1002 - Composition of Opioid Overdose Fatality Review Board
- Section 2-1003 - Review of overdose death certificates
- Section 2-1101 - Harm-reduction services